Direct binding of Bcl-2 family proteins by quercetin triggers its pro-apoptotic activity

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Bcl-2 family proteins are key regulators of apoptosis.
• Overexpression of antiapoptotic proteins is common in cancers, making them therapeutic targets.
• Quercetin, a natural flavonoid, shows promise as an anticancer agent that spares normal cells.

Purpose of the Study:

• To elucidate the mechanism of action of quercetin as an anticancer agent.
• To investigate quercetin's effects on cancer cell proliferation and apoptosis.
• To determine if quercetin directly interacts with Bcl-2 family proteins.

Main Methods:

• Multidisciplinary approach including dose-response studies, apoptosis assays, biochemical and physicochemical analyses.
• Computational calculations were employed to understand molecular interactions.
• Specific focus on interactions with the BH3 domain of Bcl-2 and Bcl-xL proteins.

Main Results:

• Quercetin demonstrated dose-dependent antiproliferative activity against cancer cells.
• Quercetin effectively induced apoptosis in cancer cells.
• Biochemical and computational data confirmed direct binding of quercetin to the BH3 domain of Bcl-2 and Bcl-xL proteins.

Conclusions:

• Quercetin inhibits the antiapoptotic activity of Bcl-2 and Bcl-xL by binding to their BH3 domains.
• This direct interaction promotes cancer cell apoptosis, highlighting quercetin's therapeutic potential.
• Quercetin represents a promising natural compound for cancer therapy.